Deutsche Bank Ag\ Compass Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.0 - $1.85 $43,476 - $80,430	43,476 Added 101.85%	86,164 $86,000
Q1 2024 May 15, 2024	SELL	$1.2 - $2.29 $2,311 - $4,410	-1,926 Reduced 4.32%	42,688 $84,000
Q3 2023 Nov 09, 2023	BUY	$1.87 - $3.25 $14,915 - $25,922	7,976 Added 21.77%	44,614 $87,000
Q2 2023 Aug 14, 2023	BUY	$2.64 - $3.48 $96,724 - $127,500	36,638 New	36,638 $116,000

93.2M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $202M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.